Rachelmycin | CAS# 69866-21-3 | DNA-Alkylating Agent

MedKoo Cat#: 565241 | Name: Rachelmycin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Rachelmycin is a novel and potent DNA-alkylating agent which inhibits TBP/DNA interaction.

Chemical Structure

Rachelmycin

CAS#69866-21-3

Theoretical Analysis

MedKoo Cat#: 565241

Name: Rachelmycin

CAS#: 69866-21-3

Chemical Formula: C37H33N7O8

Exact Mass: 703.2391

Molecular Weight: 703.71

Elemental Analysis: C, 63.15; H, 4.73; N, 13.93; O, 18.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

CC1065; CC 1065; CC-1065; NSC298223; NSC 298223; NSC-298223; Rachelmycin

IUPAC/Chemical Name

4-Hydroxy-7-(4-hydroxy-5-methoxy-7-((7bR,8aS)-7-methyl-4-oxo-1,2,4,5,8,8a-hexahydrocyclopropa[c]pyrrolo[3,2-e]indole-2-carbonyl)-1,2,3,6-tetrahydropyrrolo[3,2-e]indole-3-carbonyl)-5-methoxy-1,6-dihydropyrrolo[3,2-e]indole-3(2H)-carboxamide

InChi Key

UOWVMDUEMSNCAV-WYENRQIDSA-N

InChi Code

InChI=1S/C37H33N7O8/c1-14-12-39-27-22(45)10-23-37(24(14)27)11-15(37)13-44(23)35(49)21-9-18-16-4-6-42(28(16)30(46)32(51-2)25(18)41-21)34(48)20-8-19-17-5-7-43(36(38)50)29(17)31(47)33(52-3)26(19)40-20/h8-10,12,15,39-41,46-47H,4-7,11,13H2,1-3H3,(H2,38,50)/t15-,37+/m1/s1

SMILES Code

O=C(N1CCC2=C1C(O)=C(OC)C3=C2C=C(C(N4CCC5=C4C(O)=C(OC)C6=C5C=C(C(N7C[C@](C8)([H])[C@]98C%10=C(NC=C%10C)C(C=C79)=O)=O)N6)=O)N3)N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 703.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Tietze LF, Krewer B, von Hof JM, Frauendorf H, Schuberth I. Determination of the biological activity and structure activity relationships of drugs based on the highly cytotoxic duocarmycins and CC-1065. Toxins (Basel). 2009 Dec;1(2):134-50. doi: 10.3390/toxins1020134. Epub 2009 Dec 2. PubMed PMID: 22069536; PubMed Central PMCID: PMC3202783. 2: Chavda S, Babu B, Yanow SK, Jardim A, Spithill TW, Kiakos K, Kluza J, Hartley JA, Lee M. A novel achiral seco-cyclopropylpyrido[e]indolone (CPyI) analog of CC-1065 and the duocarmycins: synthesis, DNA interactions, in vivo anticancer and anti-parasitic evaluation. Bioorg Med Chem. 2010 Jul 15;18(14):5016-24. doi: 10.1016/j.bmc.2010.05.078. Epub 2010 Jun 4. PubMed PMID: 20579889. 3: Wu S, Jian XH, Yuan H, Jin WB, Yin Y, Wang LY, Zhao J, Tang GL. Unified Biosynthetic Origin of the Benzodipyrrole Subunits in CC-1065. ACS Chem Biol. 2017 Jun 16;12(6):1603-1610. doi: 10.1021/acschembio.7b00302. Epub 2017 May 2. PubMed PMID: 28426198. 4: Jin WB, Wu S, Jian XH, Yuan H, Tang GL. A radical S-adenosyl-L-methionine enzyme and a methyltransferase catalyze cyclopropane formation in natural product biosynthesis. Nat Commun. 2018 Jul 17;9(1):2771. doi: 10.1038/s41467-018-05217-1. PubMed PMID: 30018376; PubMed Central PMCID: PMC6050322. 5: Yuan H, Zhang J, Cai Y, Wu S, Yang K, Chan HCS, Huang W, Jin WB, Li Y, Yin Y, Igarashi Y, Yuan S, Zhou J, Tang GL. GyrI-like proteins catalyze cyclopropanoid hydrolysis to confer cellular protection. Nat Commun. 2017 Nov 14;8(1):1485. doi: 10.1038/s41467-017-01508-1. PubMed PMID: 29133784; PubMed Central PMCID: PMC5684135. 6: Mullins EA, Shi R, Eichman BF. Toxicity and repair of DNA adducts produced by the natural product yatakemycin. Nat Chem Biol. 2017 Sep;13(9):1002-1008. doi: 10.1038/nchembio.2439. Epub 2017 Jul 24. PubMed PMID: 28759018; PubMed Central PMCID: PMC5657529. 7: Chanda PB, Boyle KE, Brody DM, Shukla V, Boger DL. Synthesis and evaluation of duocarmycin SA analogs incorporating the methyl 1,2,8,8a-tetrahydrocyclopropa[c]imidazolo[4,5-e]indol-4-one-6-carboxylate (CImI) alkylation subunit. Bioorg Med Chem. 2016 Oct 15;24(20):4779-4786. doi: 10.1016/j.bmc.2016.04.050. Epub 2016 Apr 26. PubMed PMID: 27221071; PubMed Central PMCID: PMC5052114. 8: Uematsu M, Brody DM, Boger DL. A five-membered lactone prodrug of CBI-based analogs of the duocarmycins. Tetrahedron Lett. 2015 Jun 3;56(23):3101-3104. PubMed PMID: 26069351; PubMed Central PMCID: PMC4459655. 9: Patil PC, Satam V, Lee M. A Short Review on the Synthetic Strategies of Duocarmycin Analogs that are Powerful DNA Alkylating Agents. Anticancer Agents Med Chem. 2015;15(5):616-30. Review. PubMed PMID: 25511515. 10: Wolfe AL, Duncan KK, Parelkar NK, Weir SJ, Vielhauer GA, Boger DL. A novel, unusually efficacious duocarmycin carbamate prodrug that releases no residual byproduct. J Med Chem. 2012 Jun 28;55(12):5878-86. doi: 10.1021/jm300330b. Epub 2012 Jun 12. PubMed PMID: 22650244; PubMed Central PMCID: PMC3386426. 11: Huang W, Xu H, Li Y, Zhang F, Chen XY, He QL, Igarashi Y, Tang GL. Characterization of yatakemycin gene cluster revealing a radical S-adenosylmethionine dependent methyltransferase and highlighting spirocyclopropane biosynthesis. J Am Chem Soc. 2012 May 30;134(21):8831-40. doi: 10.1021/ja211098r. Epub 2012 May 21. PubMed PMID: 22612591. 12: Rayburn E, Wang W, Li M, Zhang X, Xu H, Li H, Qin JJ, Jia L, Covey J, Lee M, Zhang R. Preclinical pharmacology of novel indolecarboxamide ML-970, an investigative anticancer agent. Cancer Chemother Pharmacol. 2012 Jun;69(6):1423-31. doi: 10.1007/s00280-012-1851-9. Epub 2012 Feb 25. PubMed PMID: 22367116. 13: Zhao RY, Erickson HK, Leece BA, Reid EE, Goldmacher VS, Lambert JM, Chari RV. Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer. J Med Chem. 2012 Jan 26;55(2):766-82. doi: 10.1021/jm201284m. Epub 2012 Jan 5. PubMed PMID: 22148292. 14: Tietze LF, Schmuck K. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. Curr Pharm Des. 2011;17(32):3527-47. Review. PubMed PMID: 22074425. 15: Lajiness JP, Boger DL. Asymmetric synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benzo[e]indol-4-one (CBI). J Org Chem. 2011 Jan 21;76(2):583-7. doi: 10.1021/jo102136w. Epub 2010 Dec 30. PubMed PMID: 21192653; PubMed Central PMCID: PMC3079324. 16: Lajiness JP, Robertson WM, Dunwiddie I, Broward MA, Vielhauer GA, Weir SJ, Boger DL. Design, synthesis, and evaluation of duocarmycin O-amino phenol prodrugs subject to tunable reductive activation. J Med Chem. 2010 Nov 11;53(21):7731-8. doi: 10.1021/jm1010397. PubMed PMID: 20942408; PubMed Central PMCID: PMC2974002. 17: Lajiness JP, Boger DL. Synthesis and characterization of a cyclobutane duocarmycin derivative incorporating the 1,2,10,11-tetrahydro-9H-cyclobuta[c]benzo[e]indol-4-one (CbBI) alkylation subunit. J Am Chem Soc. 2010 Oct 6;132(39):13936-40. doi: 10.1021/ja106986f. PubMed PMID: 20839806; PubMed Central PMCID: PMC2952436. 18: Lee SY, Pfeifer GP, Lee CS. Mutation spectra induced by adozelesin in the supF gene of human XP-A fibroblasts. Arch Pharm Res. 2010 Apr;33(4):633-6. doi: 10.1007/s12272-010-0419-7. Epub 2010 Apr 27. PubMed PMID: 20422374. 19: Gauss CM, Hamasaki A, Parrish JP, Macmillan KS, Rayl TJ, Hwang I, Boger DL. Synthesis and Preliminary Evaluation of Duocarmycin Analogues Incorporating the 1,2,11,11a-Tetrahydrocyclopropa[c]naphtho[2,3-e]indol-4-one (CNI) and 1,2,11,11a-Tetrahydrocyclopropa[c]naphtho[1,2-e]indol-4-one (iso-CNI) Alkylation Subunits. Tetrahedron. 2009 Aug 15;65(33):6591-6599. PubMed PMID: 20161204; PubMed Central PMCID: PMC2713043.